Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels
HHS herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in federal workplace drug testing programs. The Department has made no revisions to the current drug testing panels for both urine and oral fluid and current required nomenclature for laboratory and Medical Review Officer R
| Agency | Health and Human Services Department |
|---|---|
| Document type | Rule |
| Published | 2026-03-13 |
| Summary | HHS herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in federal workplace drug testing programs. The Department has made no revisions to the current drug testing panels for both urine and oral fluid and current required nomenclature for laboratory and Medical Review Officer Reports, effective July 7, 2025. |
| Document number | 2026-04981 |
| Official record | https://www.federalregister.gov/documents/2026/03/13/2026-04981/mandatory-guidelines-for-federal-workplace-drug-testing-programs-authorized-testing-panels |